← Back to Search

Device

HeraBEAT™ Intervention Group for Pregnancy

N/A
Waitlist Available
Led By Yvonne S Butler Tobah, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is testing a new device that uses a smartphone to monitor fetal heart rate during pregnancy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accurate Fetal Heart Rate Detection Where Values Are Between 110 and 160 Bpm
Device Ease of Use

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HeraBEAT™ Intervention GroupExperimental Treatment1 Intervention
Subjects will monitor their fetal heart beat once weekly using the HeraBEAT™ device. After approximately 8 weeks of monitoring subjects will crossover to using the doppler fetal heart rate monitor
Group II: Standard Fetal Doppler GroupActive Control1 Intervention
Subjects will monitor their fetal heart beat once weekly using the doppler fetal heart rate monitor. After approximately 8 weeks of monitoring subjects will crossover to using the HeraBEAT™ device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HeraBEAT™
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,725 Total Patients Enrolled
Yvonne S Butler Tobah, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Medical Grade, Smartphone-based, Fetal Heart Rate Monitor for Outpatient Use
Yvonne S. Butler Tobah, MD 2021. "Medical Grade, Smartphone-based, Fetal Heart Rate Monitor for Outpatient Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04232215.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top